Table 1.
Patient characteristics and their associations with Eg5 expression.
| Variables | N (%) | Eg5 † | |
|---|---|---|---|
| Mean ± SD | p | ||
| Total | 108 (100) | 8.3 ± 16.0 # | |
| Mean age (SD, years) | 54.7 (13.4) # | ||
| Gender | 0.887 | ||
| Female | 21 (19) | 8.7 ± 10.6 | |
| Male | 87 (81) | 8.2 ± 17.1 | |
| Hepatitis virus | |||
| HBsAg positive | 75 (69) | 8.3 ± 15.6 | 0.964 |
| Anti-HCV positive | 31 (29) | 6.9 ± 16.6 | 0.578 |
| AJCC stage | 0.573 | ||
| I | 46 (43) | 7.5 ± 19.8 | |
| II | 32 (30) | 7.0 ± 8.5 | |
| III | 30 (28) | 10.9 ± 15.8 | |
| Tumor size | 0.835 | ||
| >5 cm | 48 (44) | 8.7 ± 19.3 | |
| ≤5 cm | 60 (56) | 8.0 ± 12.9 | |
| Tumor grade | 0.683 | ||
| 1 | 26 (24) | 10.3 ± 24.4 | |
| 2 | 51 (47) | 7.0 ± 14.0 | |
| 3 | 31 (29) | 8.8 ± 9.1 | |
| AFP > 400 ng/mL | 40 (37) | 9.4 ± 14.8 | 0.573 |
| Child-Pugh status | 0.828 | ||
| A | 100 (93) | 8.4 ± 16.4 | |
| B | 8 (7) | 7.1 ± 9.7 | |
Abbreviations: SD = standard deviation; HBsAg = hepatitis B virus surface antigen; HCV = hepatitis C virus; AJCC = American Joint Committee on Cancer; AFP = α-fetoprotein. # Age had a weakly positive correlation with Eg5 expression (r = 0.013, p = 0.897). † Calculated using the method described in Section 2.2. p values were conducted using the independent t test or one-way analysis of variance.